• Lavipharm launched DUROGESIC in France on Sept. 30, 2026 following French regulatory clearance for a marketing-authorization transfer.
• Marketing-authorization transfers in other markets remain in progress, with further approvals expected soon.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lavipharm SA published the original content used to generate this news brief on October 01, 2026, and is solely responsible for the information contained therein.